.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Ischemic stroke remains a leading cause of disability globally. Consequently, researchers are exploring novel therapeutic agents to mitigate brain damage. Recent evidence highlights the potential for leptin neuroprotection in stroke recovery. Leptin, primarily known for regulating appetite, acts as a potent signaling molecule in the central nervous system. A comprehensive systematic review of 17 preclinical studies involving 1,383 animals reveals that leptin administration significantly reduces brain injury.
Specifically, the hormone triggers several pro-survival signaling cascades. The analysis identified the PI3K/Akt and JAK/STAT3 pathways as critical drivers of these protective effects. These pathways help maintain cell viability by inhibiting apoptosis and reducing oxidative stress. Furthermore, leptin promotes neurogenesis and angiogenesis, which are vital for long-term functional recovery. Therefore, the hormone does not only prevent cell death but also supports the brain's natural repair mechanisms.
Notably, the meta-analysis demonstrated a significant reduction in infarct volume, with a standardized mean difference of -2.76. Beyond structural preservation, leptin also improves neurobehavioral outcomes. Animals treated with leptin showed enhanced motor coordination and sensory function. These findings suggest that leptin could provide a dual benefit by protecting tissue and improving quality of life. However, translating these rodent-based successes into human clinical trials remains the next major challenge for the scientific community.
While the preclinical data is robust, researchers must optimize delivery methods and dosage for humans. Identifying the therapeutic window is essential, as the timing of administration significantly impacts efficacy. Additionally, understanding how leptin interacts with existing therapies like thrombolysis will be crucial. Researchers are optimistic that metabolic hormones could eventually become a cornerstone of acute stroke management.
Leptin activates specific pathways, such as PI3K/Akt and JAK/STAT3, which prevent cell death and promote the growth of new blood vessels and neurons.
No, the current evidence is primarily based on preclinical animal models. Clinical trials are needed to confirm the safety and efficacy of leptin in humans.
Yes, meta-analyses show that leptin administration significantly reduces the volume of infarcted (damaged) brain tissue in rodent models of ischemia.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice. Refer to the latest local and national guidelines for clinical practice.
References
Behrouzifar S et al. Leptin-induced neuroprotection in ischemic stroke: a comprehensive systematic review and meta-analysis elucidating molecular pathways in preclinical animal models. Brain Inj. 2026 Feb 28. doi: 10.1080/02699052.2026.2636708. PMID: 41761843.
Amantea D et al. Neuroprotection by leptin in a rat model of permanent cerebral ischemia: Effects on STAT3 phosphorylation. Neurobiology of Disease. 2011.
Avraham Y et al. Leptin induces neurogenesis and angiogenesis after stroke. PubMed. 2011.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Research confirms that leptin significantly reduces brain infarct volume and enhances motor function recovery in animal models through key molecular pathway...
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
